{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:52:39Z","timestamp":1790052759640,"version":"4.0.1"},"reference-count":36,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Cardiovascular Disease"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:sec><jats:title>Objectives:<\/jats:title><jats:p>There is recent evidence that aldosterone play a role in the pathogenesis of cardiovascular disease in dialysis patients, which leads to the opportunity to block its actions for the benefit of these patients. In nondialytic chronic kidney disease, spironolactone was safe and effective in reducing left ventricular hypertrophy. However, routine use has been precluded in hemodialysis patients due to the risk of hyperkalemia. The aim of this study is to verify the safety and efficacy in regression of left ventricular hypertrophy with spironolactone in hemodialysis patients undergoing pharmacotherapeutic monitoring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We performed a controlled, randomized, double blind study evaluating 17 hemodialysis patients who received spironolactone at a dose of 12.5 mg titrated, in the second week, to 25 mg of spironolactone or placebo. The patients were treated for 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The groups were composed of eight patients (intervention) and nine patients (control). These groups did not differ in their baseline characteristics. The group receiving spironolactone had a left ventricular mass index reduction from 77 \u00b1 14.6 g\/m<jats:sup>2.7<\/jats:sup>to 69 \u00b1 10.5 g\/m<jats:sup>2.7<\/jats:sup>, p &lt; 0.04, whereas in placebo group there was an increase from 71 \u00b1 14.2 g\/m<jats:sup>2.7<\/jats:sup>to 74 \u00b1 17.4 g\/m<jats:sup>2.7<\/jats:sup>. Systolic or diastolic blood pressure did not change during the study. Potassium did not differ statistically between groups in all instances.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Spironolactone treatment in hemodialysis patients was secure and effective in regression of left ventricular hypertrophy, a major risk factor for cardiovascular events in these patients. This effect occurred in spite of blood pressure stability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration:<\/jats:title><jats:p>ClinicalTrials.gov identifier NCT01128101<\/jats:p><\/jats:sec>","DOI":"10.1177\/1753944715591448","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T23:59:39Z","timestamp":1435363179000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":38,"title":["Spironolactone is secure and reduces left ventricular hypertrophy in hemodialysis patients"],"prefix":"10.1177","volume":"9","author":[{"given":"Greicy Mara Mengue","family":"Feniman-De-Stefano","sequence":"first","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, 440 Rua Jo\u00e3o Miguel Rafael, Botucatu, CEP 18602-220, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silm\u00e9ia Garcia","family":"Zanati-Basan","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laercio Martins","family":"De Stefano","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Santi","family":"Xavier","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana D\u00f3ris","family":"Castro","sequence":"additional","affiliation":[{"name":"Dpto de Medicamentos \u2013 Faculdade de Ci\u00eancias Farmac\u00eauticas \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Costa Teixeira","family":"Caramori","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqual","family":"Barretti","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Jorge da Silva Franco","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Cuadrado","family":"Martin","sequence":"additional","affiliation":[{"name":"Dpto de Cl\u00ednica M\u00e9dica da Faculdade de Medicina de Botucatu \u2013 UNESP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"key":"bibr1-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.160960"},{"key":"bibr2-1753944715591448","author":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","year":"2004","journal-title":"DOU Bras\u00edlia"},{"key":"bibr3-1753944715591448","author":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","year":"2009","journal-title":"DOU Bras\u00edlia"},{"key":"bibr4-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0848"},{"key":"bibr5-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp256"},{"key":"bibr6-1753944715591448","first-page":"3","volume-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Benet L.","year":"1995","edition":"9"},{"key":"bibr7-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.119974"},{"key":"bibr8-1753944715591448","author":"Congresso Nacional","year":"1999","journal-title":"DOU Bras\u00edlia"},{"key":"bibr9-1753944715591448","author":"Conselho Nacional de Sa\u00fade","year":"1996","journal-title":"DOU Bras\u00edlia"},{"key":"bibr10-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20838"},{"key":"bibr11-1753944715591448","first-page":"305","volume":"105","author":"Cohn S.","year":"1985","journal-title":"J Lab Clin Med"},{"key":"bibr12-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1016\/S1073-4449(12)80028-8"},{"key":"bibr13-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.066"},{"key":"bibr14-1753944715591448","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/346985"},{"key":"bibr15-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.03.011"},{"key":"bibr16-1753944715591448","first-page":"25","volume-title":"Guia Pr\u00e1tico da Farm\u00e1cia Magistral","author":"Ferreira A.","year":"2010"},{"key":"bibr17-1753944715591448","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0022-3565(25)32607-8","volume":"217","author":"Finotti P.","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr18-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.22"},{"key":"bibr19-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2009.01256.x"},{"key":"bibr20-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199602000-00002"},{"key":"bibr21-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft409"},{"key":"bibr22-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/44.3.417"},{"key":"bibr23-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"bibr24-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.913"},{"key":"bibr25-1753944715591448","first-page":"822","volume-title":"Farmacologia","author":"Macedo J.","year":"2010"},{"key":"bibr26-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120017467"},{"key":"bibr27-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.07.017"},{"key":"bibr28-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.056"},{"key":"bibr29-1753944715591448","volume-title":"Farmacopeia Brasileira","author":"Minist\u00e9rio da Sa\u00fade","year":"2010","edition":"5"},{"key":"bibr30-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn325"},{"key":"bibr31-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.228"},{"key":"bibr32-1753944715591448","doi-asserted-by":"publisher","DOI":"10.2174\/157488607779315499"},{"key":"bibr33-1753944715591448","first-page":"24","volume":"89","author":"Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertens\u00e3o and Sociedade Brasileira de Nefrologia","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"bibr34-1753944715591448","first-page":"1","volume":"4","author":"Taylor B.","year":"2014","journal-title":"Br Med J Open"},{"key":"bibr35-1753944715591448","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.V12122768","volume":"12","author":"Zoccali C.","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"bibr36-1753944715591448","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02407.x"}],"container-title":["Therapeutic Advances in Cardiovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753944715591448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1753944715591448","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753944715591448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T22:03:47Z","timestamp":1748469827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1753944715591448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1177\/1753944715591448"],"URL":"https:\/\/doi.org\/10.1177\/1753944715591448","relation":{},"ISSN":["1753-9447","1753-9455"],"issn-type":[{"value":"1753-9447","type":"print"},{"value":"1753-9455","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}